Apocrine cystadenoma: A long-standing apocrine hidrocystoma with an adenomatous proliferation.
Connolly DM, McGeehin EL, Lee JB.
J Cutan Pathol. 2024 Mar;51(3):251-257. doi: 10.1111/cup.14573. Epub 2023 Dec 12.
Apocrine cystadenoma.
Hunter GA, Donald GF.
Australas J Dermatol. 1970 Aug;11(2):82-6. doi: 10.1111/j.1440-0960.1970.tb00449.x.
Peri-ocular proliferative apocrine hidrocystoma (cystadenoma): A clinicopathological case series.
Al Ghulaiga FM, Alsulaiman AM, Maktabi AMY, Alkatan HM.
Int J Surg Case Rep. 2024 Jan;114:109085. doi: 10.1016/j.ijscr.2023.109085. Epub 2023 Nov 20.
Apocrine cystadenoma arising on the ear.
Mitsuishi T, Nogita T, Kawashima M.
J Dermatol. 1996 Aug;23(8):583-4. doi: 10.1111/j.1346-8138.1996.tb02657.x.
Apocrine Cystadenoma of the Eyelid, a Rare Neoplasm: Expanded Immunohistologic Profile.
Charles NC, McGee RP, Kim ET.
Ophthalmic Plast Reconstr Surg. 2023 Sep-Oct 01;39(5):e142-e145. doi: 10.1097/IOP.0000000000002396. Epub 2023 Apr 3.
Sclerosing Polycystic Adenoma.
Bishop JA, Thompson LDR.
Surg Pathol Clin. 2021 Mar;14(1):17-24. doi: 10.1016/j.path.2020.09.004.
Prostate Benign Diseases.
Guimaraes CTS, Sauer LJ, Romano RFT, Pacheco EO, Bittencourt LK.
Top Magn Reson Imaging. 2020 Feb;29(1):1-16. doi: 10.1097/RMR.0000000000000227.
Nevus sebaceus with syringocystadenoma papilliferum, prurigo nodularis, apocrine cystadenoma, basaloid follicular proliferation, and sebaceoma: case report and review of nevus sebaceus-associated conditions.
Basu P, Erickson CP, Calame A, Cohen PR.
Dermatol Online J. 2020 Feb 15;26(2):13030/qt85k968bk.
Selected apocrine neoplasms.
Warkel RL.
J Cutan Pathol. 1984 Oct;11(5):437-49. doi: 10.1111/j.1600-0560.1984.tb00400.x.
Cutaneous apocrine-derived eyelid lesions: a series.
Dharmen Shah V, Resnik AB, Azzam DB, Starks VS, Callahan AE, Vagefi MR, Laver NV.
Orbit. 2025 Dec;44(6):840-849. doi: 10.1080/01676830.2025.2514249. Epub 2025 Jun 18.
